PDF (6,0 MB) - Ãrad priemyselného vlastnÃctva SR
PDF (6,0 MB) - Ãrad priemyselného vlastnÃctva SR
PDF (6,0 MB) - Ãrad priemyselného vlastnÃctva SR
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
34<br />
VESTNÍK ÚRADU PRIEMYSELNÉHO VLASTNÍCTVA <strong>SR</strong> 2 - 2010 - SK (preklady patentov)<br />
(86) PCT/FR2006/050827<br />
(87) WO 2007/026104<br />
(54) Pyrolopyridínové deriváty a ich použitie ako<br />
modulátorov receptoru PPAR<br />
(51) A61K 31/44, A61K 31/445<br />
(11) E 6257<br />
(96) 02756988.8, 6.8.2002<br />
(97) 1414451, 20.5.2009<br />
(24) 20.5.2009<br />
(31) 310536 P<br />
(32) 6.8.2001<br />
(33) US<br />
(73) EURO-CELTIQUE S.A., Luxembourg, LU;<br />
(72) BREDER Christopher, Greenwich, CT, US; OSHLACK<br />
Benjamin, New York, NY, US; WRIGHT Curtis,<br />
Norwalk, CT, US;<br />
(74) Bušová Eva, JUDr., Bratislava, SK;<br />
(86) PCT/US2002/024944<br />
(87) WO 2003/013525<br />
(54) Formulácie opoídneho agonistu s uvoľniteľným<br />
a oddeleným antagonistom<br />
(51) A61K 31/519, A61K 31/135, A61K 31/7028,<br />
A61K 31/00, A61K 31/565, A61K 31/57,<br />
A61K 31/4415, A61P 15/00, A61K 31/58<br />
(11) E 6295<br />
(96) 06753787.8, 15.5.2006<br />
(97) 1888077, 29.4.2009<br />
(24) 29.4.2009<br />
(31) 102005023301, 102006016285<br />
(32) 13.5.2005, 3.4.2006<br />
(33) DE, DE<br />
(73) Bayer Schering Pharma AG, Berlin, DE; Merck<br />
Eprova AG, Schaffhausen, CH;<br />
(72) STROTHMANN Kai, Oberursel, DE; SMITH Gavin<br />
Welch, Berlin, DE; KING Kristina, Berlin, DE;<br />
MOSER Rudolf, Schaffhausen, CH; PIETRZIK<br />
Klaus, Meckenheim, DE;<br />
(74) Čechvalová Dagmar, Bratislava, SK;<br />
(86) PCT/EP2006/004858<br />
(87) WO 2006/120035<br />
(54) Farmaceutická kompozícia obsahujúca gestagény<br />
a/alebo estrogény a 5-metyl-(6S)-tetrahydrofolát<br />
(51) A61K 31/551<br />
(11) E 6327<br />
(96) 05728747.6, 18.3.2005<br />
(97) 1727551, 9.9.2009<br />
(24) 9.9.2009<br />
(31) 0406279<br />
(32) 19.3.2004<br />
(33) GB<br />
(73) Arrow Therapeutics Limited, London, GB;<br />
(72) POWELL Kenneth, London, GB; KELSEY Richard,<br />
London, GB; CARTER Malcoml, London,<br />
GB; DOWDELL Verity, London, GB; ALBER<br />
Dagmar, London, GB; HENDERSON Elisa, London,<br />
GB;<br />
(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />
SK;<br />
(86) PCT/GB2005/001029<br />
(87) WO 2005/089771<br />
(54) Farmaceutický prostriedok obsahujúci derivát<br />
benzodiazepínu a inhibítor RVS fúzneho proteínu<br />
(51) A61K 31/553, A61P 3/00, A61P 1/00,<br />
A61P 9/00, A61P 13/00, A61P 17/00,<br />
A61P 19/00, A61P 25/00, A61P 31/00,<br />
A61P 33/00, A61P 35/00, A61P 37/00<br />
(11) E 6270<br />
(96) 05778429.0, 29.7.2005<br />
(97) 1771178, 5.8.2009<br />
(24) 5.8.2009<br />
(31) 591880 P, 647007 P<br />
(32) 29.7.2004, 27.1.2005<br />
(33) US, US<br />
(73) Creabilis Therapeutics S.P.A., Colleretto Giacosa,<br />
IT; Bio3Research Srl., Milano, IT;<br />
(72) FUMERO Silvano, Ivrea (TO), IT; PILATO Francesco<br />
P., Milano, IT; BARONE Domenico, Torino,<br />
IT; BERTARIONE RAVA Rossa Luisa, Pavone<br />
Canavese (TO), IT; MAINERO Valentina,<br />
Ivrea (TO), IT; TRAVERSA Silvio, Palazzo Canavese<br />
(TO), IT;<br />
(74) Majlingová Marta, Ing., Bratislava, SK;<br />
(86) PCT/EP2005/008258<br />
(87) WO 2006/010628<br />
(54) Použitie K-252a a inhibítora kinázy na prevenciu<br />
alebo liečenie patológií spojených s HMGB1<br />
(51) A61K 38/18, A61K 9/06<br />
(11) E 6255<br />
(96) 07712399.0, 1.3.2007<br />
(97) 1988913, 22.4.2009<br />
(24) 22.4.2009<br />
(31) 102006009437<br />
(32) 1.3.2006<br />
(33) DE<br />
(73) Bioceuticals Arzneimittel AG, Bad Vilbel, DE;<br />
(72) MACK Michael, Bad Vilbel, DE; BLASCHKE<br />
Ulrich Kurt, Wiesbaden, DE;<br />
(74) Bušová Eva, JUDr., Bratislava, SK;<br />
(86) PCT/EP2007/051947<br />
(87) WO 2007/099145<br />
(54) Kvapalná formulácia G-CSF<br />
(51) A61K 38/36, A61P 7/00, A61P 9/00<br />
(11) E 6320<br />
(96) 05752350.8, 24.6.2005<br />
(97) 1691827, 19.8.2009<br />
(24) 19.8.2009<br />
(31) 10872004, 402005<br />
(32) 25.6.2004, 13.1.2005<br />
(33) AT, AT<br />
(73) Fibrex Medical Research & Development GmbH,<br />
Wien, AT;<br />
(72) PETZELBAUER Peter, Wien, AT; ZACHAROW-<br />
SKI Kai, Düsseldorf, DE;<br />
(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />
SK;<br />
(86) PCT/AT2005/000228<br />
(87) WO 2006/000007<br />
(54) Použitie peptidu na prípravu farmaceutického<br />
prostriedku na liečenie šoku